Investors eyeing a purchase of ResMed Inc. (Symbol: RMD) stock, but tentative about paying the going market price of $220.25/share, might benefit from considering selling puts among the ...

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD ... the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's ...

We recently published a list of Jim Cramer Recently Talked About These 12 Companies. In this article, we are going to take a ...

Morgan Stanley initiated coverage of ResMed (RMD) with an Overweight rating and A$313 price target The company has a market-leading position ...

ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth in revenue and profitability. The great quarter was driven by high ...

Let’s take a look at how ResMed (NYSE:RMD) and the rest of the patient monitoring stocks fared in Q4. Patient monitoring companies within the healthcare equipment industry offer devices and ...

"Merit’s listing on Nasdaq for 35 years marks a significant milestone in our company’s history,” said Lampropoulos. “Nasdaq has been an exceptional partner, providing Merit with strong execution and ...

We think ResMed is a good business, but is it a buy today? Read our full report here, it’s free. Founded in 1989, Masimo Corporation (NASDAQ:MASI) develops and manufactures medical devices ...